BioSpace News Archive

Three late breakers, one oral presentation and 27 posters showcase AJOVY as a preventive treatment for migraine

Number of U.S. pediatric dentists projected to increase by over 60 percent within the next decade

This live webcast offers educational methodologies and practices from expert separation scientists

Bioethics International (BEI), a not-for-profit organization dedicated to raising the bar on ethics, trustworthiness and patient-centricity in the pharmaceutical industry, today announced the third publication of its Good Pharma Scorecard (GPS) in The BMJ

The new revolutionary energy-based facial and body treatment designed to create new elastin, collagen and hyaluronic acid is now at Schweiger Dermatology Group.

Pharmacy Times Continuing Education™ (PTCE), a leader in continuing education for retail, health-system, managed care and specialty pharmacists, will host the virtual symposium Use of Targeted Mechanisms to Optimize Management of Patients With Acute Myeloid Leukemia (AML) on Tuesday, Aug. 20, from 7-8:30 p.m. EDT.

Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5.XE), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, is pleased to report that its partner Zambon S.p.A. and Valeo Pharma Inc. announced today the launch of Onstryv® (safinamide) for the treatment of Parkinson’s disease in Canada.

JDRF, the leading global organization funding type 1 diabetes (T1D) research, today brought leading voices in the T1D community, including more than 160 children with the disease, to Washington to urge Congress to renew the Special Diabetes Program.

Vynca, the nation’s leading advance care planning solution, and the Louisiana Health Care Quality Forum (Quality Forum) announced today the statewide electronic LaPOST Registry is now available for clinicians throughout the state to electronically complete and submit, query, and access the Louisiana Physician Orders for Scope of Treatment (LaPOST) forms.

Successful pilot demonstrates potential new option for delivering medicines and vaccines in hard-to-reach locations and during emergencies. Additional tests planned.